Objective: To evaluate the influence of facility case volume and type on skull base chordoma treatment and overall survival (OS).
Methods: The 2004-2016 National Cancer Database was queried for skull base chordoma patients receiving definitive treatment. Facilities were categorized into 2 cohorts by calculating the mean number of patients treated per facility and using cutoff numbers that were 0.